Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,342,162
+$310,181 QoQ
Shares Held
1,119
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,858
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAZARI CAPITAL MANAGEMENT, INC. holds $11,558,274 across 8 Drug Manufacturers - General names. LLY ranks #4 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
16,094 | $4,049,894 | |
| 2 | JNJ |
Johnson & Johnson
|
6,179 | $1,569,280 | |
| 3 | PFE |
Pfizer Inc
|
64,489 | $1,552,895 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
1,119 | $1,342,162 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,208 | $991,524 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,710 | $733,735 | |
| 7 | AMGN |
Amgen Inc
|
1,870 | $677,164 | |
| 8 | GSK |
GSK plc
|
12,240 | $641,620 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,342,162 | 1,119 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,031,981 | 1,122 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,205,791 | 1,122 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $856,086 | 1,122 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $531,639 | 682 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $566,574 | 686 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $893,976 | 1,158 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $456,259 | 515 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $431,866 | 477 | Shares | Sole | 2024-09-09 | |
| 2024-03-31 | $233,388 | 300 | Shares | Sole | 2024-06-24 | |
| No filing history on record for this holder in this stock. | ||||||